PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
WIRE vs. BMY
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


WIREBMY

Fundamentals


WIREBMY
Market Cap$4.58B$99.61B
EPS$19.04-$3.25
PEG Ratio2.092.22
Total Revenue (TTM)$1.90B$46.51B
Gross Profit (TTM)$420.64M$32.93B
EBITDA (TTM)$277.22M$17.96B

Correlation

-0.50.00.51.00.2

The correlation between WIRE and BMY is 0.19, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

WIRE vs. BMY - Performance Comparison

The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


0.00%2,000.00%4,000.00%6,000.00%8,000.00%10,000.00%AprilMayJuneJulyAugustSeptember
10,748.52%
899.67%
WIRE
BMY

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

WIRE vs. BMY - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Encore Wire Corporation (WIRE) and Bristol-Myers Squibb Company (BMY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


WIRE
Sharpe ratio
The chart of Sharpe ratio for WIRE, currently valued at 2.58, compared to the broader market-4.00-2.000.002.002.58
Sortino ratio
The chart of Sortino ratio for WIRE, currently valued at 3.60, compared to the broader market-6.00-4.00-2.000.002.004.003.60
Omega ratio
The chart of Omega ratio for WIRE, currently valued at 1.48, compared to the broader market0.501.001.502.001.48
Calmar ratio
The chart of Calmar ratio for WIRE, currently valued at 4.63, compared to the broader market0.001.002.003.004.005.004.63
Martin ratio
The chart of Martin ratio for WIRE, currently valued at 18.80, compared to the broader market-10.00-5.000.005.0010.0015.0020.0018.80
BMY
Sharpe ratio
The chart of Sharpe ratio for BMY, currently valued at -0.52, compared to the broader market-4.00-2.000.002.00-0.52
Sortino ratio
The chart of Sortino ratio for BMY, currently valued at -0.61, compared to the broader market-6.00-4.00-2.000.002.004.00-0.61
Omega ratio
The chart of Omega ratio for BMY, currently valued at 0.91, compared to the broader market0.501.001.502.000.91
Calmar ratio
The chart of Calmar ratio for BMY, currently valued at -0.28, compared to the broader market0.001.002.003.004.005.00-0.28
Martin ratio
The chart of Martin ratio for BMY, currently valued at -0.80, compared to the broader market-10.00-5.000.005.0010.0015.0020.00-0.80

WIRE vs. BMY - Sharpe Ratio Comparison


Rolling 12-month Sharpe Ratio-2.00-1.000.001.002.003.00AprilMayJuneJulyAugustSeptember
2.58
-0.52
WIRE
BMY

Dividends

WIRE vs. BMY - Dividend Comparison

WIRE has not paid dividends to shareholders, while BMY's dividend yield for the trailing twelve months is around 4.82%.


TTM20232022202120202019201820172016201520142013
WIRE
Encore Wire Corporation
0.03%0.04%0.06%0.04%0.17%0.14%0.16%0.16%0.18%0.16%0.21%0.18%
BMY
Bristol-Myers Squibb Company
4.82%4.44%3.00%2.36%3.69%2.55%3.08%2.55%1.95%2.17%2.46%3.31%

Drawdowns

WIRE vs. BMY - Drawdown Comparison


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%AprilMayJuneJulyAugustSeptember
-0.48%
-34.84%
WIRE
BMY

Volatility

WIRE vs. BMY - Volatility Comparison

The current volatility for Encore Wire Corporation (WIRE) is 0.00%, while Bristol-Myers Squibb Company (BMY) has a volatility of 5.60%. This indicates that WIRE experiences smaller price fluctuations and is considered to be less risky than BMY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%5.00%10.00%15.00%AprilMayJuneJulyAugustSeptember0
5.60%
WIRE
BMY

Financials

WIRE vs. BMY - Financials Comparison

This section allows you to compare key financial metrics between Encore Wire Corporation and Bristol-Myers Squibb Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items